Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Lancet Regional Health. Americas|September 16, 2024
Venous thromboembolism prevention program implementation in a community oncology practice: a cohort studySteven Ades, Yonatan Resnick, Jacob Barker, et al.JAMA Network Open|January 13, 2021
Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate CancerNataniel H Lester-Coll, Steven Ades, James B Yu, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 13, 2020
Prospective evaluation of drug-drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulationHank K Ng, Britny G Rogala, Steven Ades, et al.JCO Oncology Practice|April 9, 2020
Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer ClinicChris E Holmes, Steven Ades, Susan Gilchrist, et al.JCO Oncology Practice|April 6, 2026
Impact of Venous Thrombosis Prevention in Ambulatory Oncology: Importance of Guideline AdherenceChris E Holmes, Karlyn A Martin, Derek Devine, et al.Journal of Gastrointestinal Oncology|May 18, 2023
'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancerLuke M Higgins, Nataniel H Lester-Coll, Steven Ades, et al.Journal of Cellular Physiology|April 18, 2018
Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer interventionNicholas H Farina, Areg Zingiryan, Michael A Vrolijk, et al.Annals of Surgical Oncology|July 16, 2014
Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinomaMonisha Sudarshan, Thierry Alcindor, Steven Ades, et al.Cancer Medicine|May 6, 2023
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinomaDylan B Ness, Darcy B Pooler, Steven Ades, et al.Biomarker Research|May 2, 2018
NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumorsMichelle X Yang, Ryan F Coates, Abiy Ambaye, et al.Pageof 3